SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Engy Mohamed El-Ghitany, Moataza M. Abdel Wahab, Ekram W. Abd El-Wahab, Safaa Hassouna, Azza G. Farghaly, A comprehensive hepatitis C virus risk factors meta-analysis (1989–2013); Do they differ in Egypt?, Liver International, 2015, 35, 2
  2. 2
    Ashley Arezou Minaei, Kris V Kowdley, ABT-450/ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus, Expert Opinion on Pharmacotherapy, 2015, 16, 6, 929

    CrossRef

  3. 3
    Amira Mohsen, Adeline Bernier, Lenaig LeFouler, Elisabeth Delarocque-Astagneau, Mai El-Daly, Sherif El-Kafrawy, Salwa El-Mango, Mohamed Abdel-Hamid, Mohsen Gadallah, Gamal Esmat, Mostafa K. Mohamed, Arnaud Fontanet, Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C, Tropical Medicine & International Health, 2015, 20, 1
  4. 4
    Ingmar Wolffram, David Petroff, Olaf Bätz, Katrin Jedrysiak, Jan Kramer, Hannelore Tenckhoff, Thomas Berg, Johannes Wiegand, Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios, Journal of Hepatology, 2015,

    CrossRef

  5. 5
    Carolina Simunovic, Michi M. Shinohara, Complications of Decorative Tattoos: Recognition and Management, American Journal of Clinical Dermatology, 2014, 15, 6, 525

    CrossRef

  6. 6
    Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Nicola Coppola, Guglielmo Borgia, GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection, Expert Review of Anti-infective Therapy, 2014, 12, 10, 1179

    CrossRef

  7. 7
    Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia, Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?, Expert Review of Anti-infective Therapy, 2014, 12, 7, 763

    CrossRef

  8. 8
    Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia, Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus, Expert Opinion on Investigational Drugs, 2014, 23, 9, 1211

    CrossRef

  9. 9
    Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Giuseppe Castaldo, Guglielmo Borgia, Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection, Expert Opinion on Investigational Drugs, 2014, 23, 4, 561

    CrossRef

  10. 10
    Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Emanuela Zappulo, Giuseppe Castaldo, Guglielmo Borgia, MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection, Expert Opinion on Investigational Drugs, 2014, 23, 5, 719

    CrossRef

  11. 11
    Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia, Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection, Expert Review of Anti-infective Therapy, 2014, 12, 9, 1033

    CrossRef

  12. 12
    Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Guglielmo Borgia, Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus, Expert Review of Anti-infective Therapy, 2014, 12, 7, 775

    CrossRef